Global Antidiabetics Market By Product, Insulin (Rapid-acting analog, Long-acting analog, Premixed insulin, Short-acting analog, Intermediate-acting insulin) Drug class (Alpha-glucosidase inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon-like peptide) agonists, DPP-IV (Dipeptidyl Peptidase) inhibitors, Meglitinides, SGLT-II (Sodium-Glucose Transport Proteins) inhibitors, Thiazolidinedione) By Route of administration (Oral, Subcutaneous, Intravenous) By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) By Diabetes Type (Type 1, Type 2) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview Global Antidiabetics Market size is expected to be worth around USD 246.8 Billion by 2033 from USD 83.1 Billion in 2023, growing at a CAGR of 11.5% during the forecas...